Click a link below to view the mailing archive as if it had been sent to you.
| 2023-09-30 00:15 | | In label expansion bid, AbbVie and Roche's Venclexta falls short in multiple myeloma subset and more... |
| 2023-09-29 12:15 | | Madrigal Pursues $500M Public Offering with NASH Market Up for Grabs and more... |
| 2023-09-29 00:15 | | FDA could furlough nearly one-fifth of staff by Sunday and more... |
| 2023-09-28 12:15 | | FDA approves Amicus Therapeutics' muscle disorder treatment and more... |
| 2023-09-28 00:15 | | FDA Adcomm Rejects BrainStorm’s ALS Therapy in Nearly Unanimous Vote and more... |
| 2023-09-27 12:15 | | AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program and more... |
| 2023-09-27 00:15 | | Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy and more... |
| 2023-09-26 12:15 | | Gilead Sciences, after trial win, moves ahead with $247M settlement in HIV antitrust case and more... |
| 2023-09-26 00:15 | | Coherus hits FDA hurdles for PD-1 drug, Neulasta biosimilar on-body injector and more... |
| 2023-09-25 12:15 | | FDA staff hold ‘major concerns’ with Brainstorm ALS therapy, documents show and more... |
| 2023-09-25 00:15 | | How a looming government shutdown could affect healthcare and more... |
| 2023-09-23 00:15 | | Why a hidden message in Ozempic’s logo represents a big shift in drug branding and more... |
| 2023-09-22 12:15 | | Covid Drug Paxlovid Now Less Effective Than In Early Trials—But It’s Still Great At Preventing Death and more... |
| 2023-09-22 00:15 | | Novo Nordisk Foundation to establish €127 million cell therapy plant and more... |
| 2023-09-21 12:15 | | AstraZeneca refused to pay full bonus to US remote worker, lawsuit claims and more... |
| 2023-09-21 00:15 | | Intarcia, a failed diabetes "unicorn," could be resurrected and more... |
| 2023-09-20 12:15 | | Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans and more... |
| 2023-09-20 00:15 | | Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug and more... |
| 2023-09-19 12:15 | | DeepMind’s New AI Can Predict Genetic Diseases and more... |
| 2023-09-19 00:15 | | Pfizer's 'entrenched' tafamidis franchise will be tough to challenge for Alnylam, BridgeBio: analysts and more... |
| 2023-09-18 12:15 | | DOJ, Chamber of Commerce Tussle in Court Over IRA’s Drug Price Negotiations and more... |
| 2023-09-18 00:15 | | In pleasant surprise for GSK, FDA approves Jakafi challenger Ojjaara in broad blood cancer use and more... |
| 2023-09-15 12:15 | | Bayer CEO plots management cuts as first step in larger overhaul and more... |
| 2023-09-15 00:15 | | After Kenvue spinoff, J&J says it's 'uniting' Janssen and medtech segments under one brand and more... |
| 2023-09-14 12:15 | | Bristol Myers plans to double experimental treatments to expand research pipeline and more... |
| 2023-09-14 00:15 | | GE Healthcare's Independence, Acquisitions, & Bright Future and more... |
| 2023-09-13 12:15 | | HHS argues Merck 'lacks standing' to sue over Medicare price negotiations and more... |
| 2023-09-13 00:15 | | CDC recommends updated Covid vaccines for everyone 6 months and older and more... |
| 2023-09-12 12:15 | | 2Seventy CEO Leschly to step down as company cuts staff, spending and more... |
| 2023-09-12 00:15 | | Pfizer, Moderna score FDA nods for next round of seasonal COVID-19 vaccines and more... |
| 2023-09-11 12:15 | | Signal: Kroger to pay up to $1.4bn to settle opioid crisis lawsuits and more... |
| 2023-09-11 00:15 | | After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin and more... |
| 2023-09-08 12:15 | | AbbVie’s Humira to Take Hit from Biosimilars, Next-Gen Therapies: Report and more... |
| 2023-09-08 00:15 | | Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit and more... |
| 2023-09-07 12:15 | | Massachusetts' biotech job boom and more... |
| 2023-09-06 12:15 | | J&J sends blood pressure drug back to Idorsia and more... |
| 2023-09-06 00:15 | | Novartis files suit against IRA after blockbuster Entresto makes CMS' price negotiations list and more... |
| 2023-09-05 12:15 | | Weight-loss drug maker Novo Nordisk becomes Europe’s most valuable company and more... |
| 2023-09-02 00:15 | | FTC allows Amgen’s $27.8B purchase of Horizon to proceed and more... |
| 2023-09-01 12:15 | | Foghorn Therapeutics doses first patient in AML therapy trial and more... |
| 2023-09-01 00:15 | | ‘We’re in the 1999 of the internet era’: a16z’s Julie Yoo on fintech’s potential and the digital health market and more... |
